ASCO disaster


anonymous

Guest
Our booth looks has a bad acid trip feel, with a cardboard tree that looks like we stole it from an elementary school play, as our focal point.

No splash or buzz from our data. No mention in the GU secession…at all.

Yet our dumb marketers are so proud and “what a great ASCO this is”. Dumb people keep on dumbing.
 


Our booth looks has a bad acid trip feel, with a cardboard tree that looks like we stole it from an elementary school play, as our focal point.

No splash or buzz from our data. No mention in the GU secession…at all.

Yet our dumb marketers are so proud and “what a great ASCO this is”. Dumb people keep on dumbing.
The above is true. It's so embarrassing. When you walk the exhibit hall we look exactly how we are viewed...as a pretender.

Booth was lame, traffic was low, our reputation, still bad. Still had the chance to interview and network so hopefully this will be my last ASCO with this sinking ship.
 








Exel is lipstick on a pig. Merck isn't that dumb. Big Pharma is going to wait until Little Pharma hits the floor and then pick up the pieces on sale.
If that’s the case, what does that make us? The pig sty where the pig poops?

Also, Wall Street seems to disagree, and that pig keeps kicking our ass…and Merck is doing more studies with them…so.

Your statement rings of jealousy and a lack of knowledge.
 








Exel is lipstick on a pig. Merck isn't that dumb. Big Pharma is going to wait until Little Pharma hits the floor and then pick up the pieces on sale.
You win for the dumbest post on the internet...Guess you didn't see the Blueprint buyout for $9.5B having only $700M in revenue and a "who knows?" pipeline.

Exel is hitting $2B in revenue a year with a valuation of $11.6B and a tangible late stage product that is projected to do more than double of current Cabo revenue. Do the math dopey. Their buyout price will be well over $60, and it is coming soon.

All the while you'll be sitting here making substantially less money, being micromanaged by idiots, selling a drug no one cares about or likes, at a company with a terrible reputation, while driving in a Rav4, which is basically a High School starter car. Keep on losing, loser.

HHC BABY!!!!
 


You win for the dumbest post on the internet...Guess you didn't see the Blueprint buyout for $9.5B having only $700M in revenue and a "who knows?" pipeline.

Exel is hitting $2B in revenue a year with a valuation of $11.6B and a tangible late stage product that is projected to do more than double of current Cabo revenue. Do the math dopey. Their buyout price will be well over $60, and it is coming soon.

All the while you'll be sitting here making substantially less money, being micromanaged by idiots, selling a drug no one cares about or likes, at a company with a terrible reputation, while driving in a Rav4, which is basically a High School starter car. Keep on losing, loser.

HHC BABY!!!!
I wish I had a rav 4 ….. lame ass Eisai
 















Write your reply...